Silver Book Fact

Healthcare costs of atrial fibrillation

Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations at 9%, further investigations at 8%, loss of work at 6%, and paramedical procedures at 2%.

Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize. Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study. Am Heart J. 2004; 147(1): 121-6. http://www.ahjonline.com/article/S0002-8703%2803%2900524-6/abstract

Reference

Title
Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study
Publication
Am Heart J
Publication Date
2004
Authors
Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize
Volume & Issue
Volume 147, Issue 1
Pages
121-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Projected AFib prevalence
    Projected increases in the prevalence of Afib  
  • Projected AFib incidence, 2050
    If current incidence estimates are applied to Census Bureau projections, by 2050 the number of Americans with atrial fibrillation could exceed 12 million. If increases in incidence continue, that number could…  
  • Atrial fibrillation prevalence, 2012
    Atrial fibrillation is estimated to impact between 2.7 and 6.1 million Americans.  
  • AFib-related stroke and disability
    Stroke is very disabling and individuals recovering from a stroke who also have AFib have a higher risk of remaining disable or handicapped compared to stroke patients without AFib.  
  • Quality of life in AFib patients
    Individuals with AFib report substantially worse quality of life compared to those without the disease